Dual energy CT (DECT) is a technology that is gaining widespread acceptance, particularly for its abdominopelvic applications. Pancreatic pathologies are an ideal application for the many advantages offered by dual energy post-processing. This article reviews the current literature on dual energy CT pancreatic imaging, specifically in the evaluation of pancreatic adenocarcinoma, other solid and cystic pancreatic neoplasms, and pancreatitis. The advantages in characterization and quantification of enhancement, detection of subtle lesions, and potential reduction of imaging phases and contrast usage are reviewed. We also discuss directions for future research, and the ideal use of dual energy CT in routine clinical practice.